Brian M. Silver - 15 Jul 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Chief Financial Officer
Signature: /s/ Brian M. Silver
Issuer symbol: TCRX
Transactions as of: 15 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Jul 2021, 16:40:26 UTC
Next filing: 13 Sep 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRX	Stock Option (right to buy)	Award	$0	+250,441		$0.000000	250,441	15 Jul 2021	Voting Common Stock	250,441	$15.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following May 3, 2021, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the issuer. If Mr. Silver's employment is terminated without cause or for good reason within the three months prior to a change of control or within 12 months at or following a change of control, any unvested shares or equity awards shall immediately vest.

Content

The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following May 3, 2021, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the issuer. If Mr. Silver's employment is terminated without cause or for good reason within the three months prior to a change of control or within 12 months at or following a change of control, any unvested shares or equity awards shall immediately vest.